Atlas Trials

Metastatic HER2-positive Breast Cancer

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Metastatic HER2-positive Breast Cancer

RecordFirmDate
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer (NCT06435429)Jazz Pharmaceuticals2024-08-13
Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy (NCT02252887)Memorial Sloan Kettering Cancer Center2015-01-12

Track Metastatic HER2-positive Breast Cancer automatically

Every clearance here is in the API, with alerts when new ones post.